ARFNZ Criticizes Health Ministry's Latest E-Cigarette Regulations

Dec.05.2022
ARFNZ Criticizes Health Ministry's Latest E-Cigarette Regulations
New Zealand respiratory fund criticizes Health Department's latest outbreak regulations but advocates reducing tobacco harm instead of attacking e-cigarettes.

The latest outbreak from the Ministry of Health is disappointing, but unfortunately not surprising, according to Nancy Loucas, Executive Coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), in response to the Asthma and Respiratory Foundation NZ (ARFNZ).


She made the comment after ARFNZ claimed that the Ministry of Health had not achieved a proper balance with New Zealand's e-cigarette regulations.


ARFNZ's exaggerations and unfounded claims about e-cigarettes persist, but in reality, New Zealand has successfully implemented a harm reduction strategy for tobacco, leading to a smoke-free New Zealand by 2025. According to Ms. Loucas, ARFNZ should focus their attacks on combustible cigarettes instead.


CAPHRA was shocked to learn from the latest official statistics that ARFNZ is continuing on the path of new prohibitionism. Earlier this month, it was revealed that New Zealand's smoking rate has dropped from 9.4% of adults smoking daily a year ago to a historic low of 8%.


The Smoke-Free Environment and Regulated Products (Smoked Tobacco) Amendment is currently under parliamentary review. Its aim is to restrict the attractiveness and accessibility of cigarettes.


Ms. Lucas stated that ARFNZ should only be focusing on the Smoke-free Amendment Bill. Instead, they seem determined to continuously undermine and criticize the Ministry of Health's position on e-cigarettes. The issue here is cigarettes, not safer nicotine alternatives that save the lives of thousands of New Zealand smokers every year.


According to CAPHRA, New Zealand's smoke-free and THR policies are being studied and replicated by many other countries. Recently, a parliamentary delegation from Malaysia visited New Zealand to learn how smoking rates were halved in the past decade. New Zealand's regulatory framework is also crucial for recent regulations in the Philippines, and even Thailand is considering creating its own regulations based on New Zealand's model.


We urge the Deputy Minister of Health, Dr. Ayesha Verrall, to continue down the path of Tobacco Harm Reduction (THR), which has been successful in helping adult New Zealand smokers switch to e-cigarettes - a highly effective and harm-reducing smoking cessation tool. It is not the time to be distracted by minor issues.


We also urge ARFNZ to follow science and facts. Let's focus on the real issue - combustible tobacco," said Nancy Loucas.


2FIRSTS will continue to provide ongoing coverage of this topic, with future updates available on the 2FIRSTS app. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
APUS has introduced the Chloe 50K disposable vape, which has appeared across U.S.-facing online retail channels including Element Vape and Vapesourcing. The device combines a purse-inspired body and chain attachment with a 20ml e-liquid capacity, 1,250mAh rechargeable battery, dual mesh coil, and battery and e-liquid indicators. It is rated for up to 50,000 puffs. The product does not appear on the FDA’s current list of authorized e-cigarettes, and U.S. retail availability does not indicate FDA marketing authorization.
Jul.15
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Ukrainian Media: Polish Vape Distributor Evapify Allegedly Linked to Russian Businessman Named in U.S. “Russia Oligarch Report”
Ukrainian Media: Polish Vape Distributor Evapify Allegedly Linked to Russian Businessman Named in U.S. “Russia Oligarch Report”
According to an investigative report by Euromaidan Press, a Ukrainian English-language independent media outlet, Russian businessman Oleg Boyko has been sanctioned by Ukraine, Poland, Australia and Canada, but has not been added to the European Union’s sanctions list. The report alleges that Evapify, a Polish vape distributor with financial and personal ties to Boyko, holds a significant position in Poland’s disposable vape market.
News
Jun.01
Malaysia Nicotine Vape Market Faces Legal Uncertainty Over Tax and Poisons List Ruling
Malaysia Nicotine Vape Market Faces Legal Uncertainty Over Tax and Poisons List Ruling
Malaysia’s Finance Minister Anwar Ibrahim said duties and taxes on nicotine-containing vape products will be determined in line with the Court of Appeal’s ruling on whether liquid or gel nicotine can be exempted from the Poisons List under the Poisons Act 1952, a case that could affect the legal basis for vape taxation, retail sales and future ban policy.
Jun.29
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
British American Tobacco (BAT) plans to cut about 5,500 jobs globally and shift around 3,500 roles to strategic partners by the end of 2026, affecting about 9,000 roles in total, as the company seeks to simplify operations, strengthen technology capabilities and deliver £600 million in annual savings by 2028.
BAT
Jun.29